Chalfont St Peter, United Kingdom

David J Knight

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David J Knight. Retrieved from https://idiyas.com/inventor/david-j-knight-2wwv3khw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of David J Knight

Introduction

David J Knight is a notable inventor based in Chalfont St Peter, GB. He has made significant contributions to the field of antiviral compounds, showcasing his expertise and innovative spirit. His work has led to the development of a patent that holds promise for future medical applications.

Latest Patents

David J Knight holds a patent for "Imidazopyridayine derivatives having antiviral activity." This patent includes compounds of the formula: ##STR1## wherein R.sub.1, R.sub.3, and R.sub.4 each independently represents a hydrogen atom or a protecting group. This innovation highlights his commitment to advancing antiviral research.

Career Highlights

Throughout his career, David has been associated with Glaxo Group Limited, a leading pharmaceutical company. His role there has allowed him to work on groundbreaking research and development projects that aim to improve health outcomes.

Collaborations

David has collaborated with esteemed colleagues, including David I Scopes and Richard Storer. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

David J Knight's contributions to antiviral research through his patent and collaborations reflect his dedication to advancing medical science. His work continues to inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…